Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1999
06/09/1999EP0920322A1 Treatment of autoimmune diseases
06/09/1999EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
06/09/1999EP0920310A1 Use of aminothiolester derivatives in pharmaceutics
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0839045A4 Interleukin-1 receptor-associated protein kinase and assays
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals
06/09/1999EP0630232B1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor
06/09/1999CN1219171A Benzofuran carboxamides and their therapeutic use
06/09/1999CN1218833A Polypeptide with cell withering promoting activity
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/08/1999US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration
06/08/1999US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910427 Protein derivatives formed by replacement, substitution, or chemical modification of amino acids 57 and/or 60 having increased activity; for immunosuppressives/allergy treatments
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999US5910306 Transdermal delivery system for antigen
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA1340589C Therepeutic nucleosides
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027106A1 NOVEL guaA
06/03/1999WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027078A1 Chemokine alpha-5
06/03/1999WO1999026961A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026656A1 Monoclonal human natural antibodies
06/03/1999WO1999026654A1 Vaccines with an ltb adjuvant
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999011275A3 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311683A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2310892A1 Chemokine alpha-5
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/03/1999CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/02/1999EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919544A1 Compounds useful for treating allergic and inflammatory diseases
06/02/1999EP0919243A1 Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918794A2 Uses for wnt polypeptides
06/02/1999EP0918787A1 Compositions and methods for antisense inhibition of protein translation
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918747A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
06/02/1999EP0918537A1 Use of proteolytic enzymes for influencing cytokines
06/02/1999EP0918530A1 Preparation of immunostimulating agents based on propionibacteria
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
06/02/1999EP0680513B1 Lysosomal targeting of immunogens
06/02/1999EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect
06/02/1999CN1218472A Pharmaceutically useful compounds
06/02/1999CN1218412A Peptide-base immunotherapeutic agent for allergic diseases
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
06/02/1999CN1218408A Method of treatment
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218404A HLA binding peptides and their uses
06/02/1999CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
06/02/1999CN1218397A Ethene containing solutions and use thereof in methods of therapy or prophylaxis
06/02/1999CN1218368A Method for treating common cold or allergic rhinitis
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CN1217929A Chinese medicine for AlDs and preparing process therefor
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908841 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection
06/01/1999US5908837 Antiinflammatory agent
06/01/1999US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
06/01/1999US5908627 Antigen associated with Type I diabetes mellitus
06/01/1999US5908626 Genetic engineering
06/01/1999CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/28/1999CA2223225A1 Method for inhibiting in vivo immune response
1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1172